Levels of circulating CD45dimCD34+VEGFR2+ progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2011-03

AUTHORS

F Farace, M Gross-Goupil, E Tournay, M Taylor, N Vimond, N Jacques, F Billiot, A Mauguen, C Hill, B Escudier

ABSTRACT

BACKGROUND: Predicting the efficacy of antiangiogenic therapy would be of clinical value in patients (pts) with metastatic renal cell carcinoma (mRCC). We tested the hypothesis that circulating endothelial cell (CEC), bone marrow-derived CD45(dim)CD34(+)VEGFR2(+) progenitor cell or plasma angiogenic factor levels are associated with clinical outcome in mRCC pts undergoing treatment with tyrosine kinase inhibitors (TKI). METHODS: Fifty-five mRCC pts were prospectively monitored at baseline (day 1) and day 14 during treatment (46 pts received sunitinib and 9 pts received sorafenib). Circulating endothelial cells (CD45(-)CD31(+)CD146(+)7-amino-actinomycin (7AAD)(-) cells) were measured in 1 ml whole blood using four-color flow cytometry (FCM). Circulating CD45(dim)CD34(+)VEGFR2(+)7AAD(-) progenitor cells were measured in progenitor-enriched fractions by four-color FCM. Plasma VEGF, sVEGFR2, SDF-1α and sVCAM-1 levels were determined by ELISA. Correlations between baseline CEC, CD45(dim)CD34(+)VEGFR2(+)7AAD(-) progenitor cells, plasma factors, as well as day 1-day 14 changes in CEC, CD45(dim)CD34(+)VEGFR2(+)7AAD(-) progenitor, plasma factor levels, and response to TKI, progression-free survival (PFS) and overall survival (OS) were examined. RESULTS: No significant correlation between markers and response to TKI was observed. No association between baseline CEC, plasma VEGF, sVEGFR-2, SDF-1α, sVCAM-1 levels with PFS and OS was observed. However, baseline CD45(dim)CD34(+)VEGFR2(+)7AAD(-) progenitor cell levels were associated with PFS (P=0.01) and OS (P=0.006). Changes in this population and in SDF-1α levels between day 1 and day 14 were associated with PFS (P=0.03, P=0.002). Changes in VEGF and SDF-1α levels were associated with OS (P=0.02, P=0.007). CONCLUSION: Monitoring CD45(dim)CD34(+)VEGFR2(+) progenitor cells, plasma VEGF and SDF-1α levels could be of clinical interest in TKI-treated mRCC pts to predict outcome. More... »

PAGES

1144

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bjc.2011.72

DOI

http://dx.doi.org/10.1038/bjc.2011.72

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1027792566

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21386843


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigens, CD34", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Renal Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoietic Stem Cells", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kidney Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukocyte Common Antigens", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Kinase Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein-Tyrosine Kinases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vascular Endothelial Growth Factor A", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vascular Endothelial Growth Factor Receptor-2", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Translational Research Laboratory, Institut de Canc\u00e9rologie Gustave Roussy, 114 rue Edouard Vaillant, 94805 Villejuif, France", 
            "INSERM U 981 \u2018Identification of molecular predictors and new targets for cancer treatment\u2019, Institut de Canc\u00e9rologie Gustave Roussy, University of Paris-Sud, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Farace", 
        "givenName": "F", 
        "id": "sg:person.01126051072.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126051072.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Department of Medicine, Institut de Canc\u00e9rologie Gustave Roussy, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gross-Goupil", 
        "givenName": "M", 
        "id": "sg:person.01252672277.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252672277.93"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Department of Biostatistics, Institut de Canc\u00e9rologie Gustave Roussy, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tournay", 
        "givenName": "E", 
        "id": "sg:person.01360076563.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01360076563.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Translational Research Laboratory, Institut de Canc\u00e9rologie Gustave Roussy, 114 rue Edouard Vaillant, 94805 Villejuif, France", 
            "INSERM U 981 \u2018Identification of molecular predictors and new targets for cancer treatment\u2019, Institut de Canc\u00e9rologie Gustave Roussy, University of Paris-Sud, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Taylor", 
        "givenName": "M", 
        "id": "sg:person.0660375370.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660375370.75"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Translational Research Laboratory, Institut de Canc\u00e9rologie Gustave Roussy, 114 rue Edouard Vaillant, 94805 Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vimond", 
        "givenName": "N", 
        "id": "sg:person.01036122025.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036122025.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Translational Research Laboratory, Institut de Canc\u00e9rologie Gustave Roussy, 114 rue Edouard Vaillant, 94805 Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jacques", 
        "givenName": "N", 
        "id": "sg:person.0770006625.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0770006625.60"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Translational Research Laboratory, Institut de Canc\u00e9rologie Gustave Roussy, 114 rue Edouard Vaillant, 94805 Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Billiot", 
        "givenName": "F", 
        "id": "sg:person.01360655007.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01360655007.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Department of Biostatistics, Institut de Canc\u00e9rologie Gustave Roussy, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mauguen", 
        "givenName": "A", 
        "id": "sg:person.01362554046.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362554046.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Department of Biostatistics, Institut de Canc\u00e9rologie Gustave Roussy, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hill", 
        "givenName": "C", 
        "id": "sg:person.0601364507.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601364507.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Gustave Roussy", 
          "id": "https://www.grid.ac/institutes/grid.14925.3b", 
          "name": [
            "Department of Medicine, Institut de Canc\u00e9rologie Gustave Roussy, Villejuif, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Escudier", 
        "givenName": "B", 
        "id": "sg:person.01304252172.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01304252172.82"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1093/emboj/18.14.3964", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000096470"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.0708148104", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000397108"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ccr.2006.11.021", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000989893"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature04186", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001795574", 
          "https://doi.org/10.1038/nature04186"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature04186", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001795574", 
          "https://doi.org/10.1038/nature04186"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature04186", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001795574", 
          "https://doi.org/10.1038/nature04186"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1479-5876-5-32", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001875982", 
          "https://doi.org/10.1186/1479-5876-5-32"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.0507158102", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002444282"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm988", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003700365", 
          "https://doi.org/10.1038/nm988"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm988", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003700365", 
          "https://doi.org/10.1038/nm988"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.0710516105", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004176363"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa065044", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007947936"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/moh.0b013e32832bbcab", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010572209"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/moh.0b013e32832bbcab", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010572209"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/moh.0b013e32832bbcab", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010572209"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/moh.0b013e32832bbcab", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010572209"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc2442", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013847179", 
          "https://doi.org/10.1038/nrc2442"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-04-1443", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014291431"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.19.5511", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017988502"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc1946", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018735013", 
          "https://doi.org/10.1038/nrc1946"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc1946", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018735013", 
          "https://doi.org/10.1038/nrc1946"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm1200", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020541056", 
          "https://doi.org/10.1038/nm1200"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm1200", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020541056", 
          "https://doi.org/10.1038/nm1200"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6605477", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020767820", 
          "https://doi.org/10.1038/sj.bjc.6605477"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6605477", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020767820", 
          "https://doi.org/10.1038/sj.bjc.6605477"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1101/gad.436307", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023814636"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa060655", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025111240"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0022-5347(05)68049-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027421869"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0022-5347(05)68049-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027421869"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1593/neo.05592", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034339541"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6604383", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035947940", 
          "https://doi.org/10.1038/sj.bjc.6604383"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jim.2008.07.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037057792"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-08-2363", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038609521"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdm367", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040378769"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.1150224", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044864905"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm1101-1194", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050308225", 
          "https://doi.org/10.1038/nm1101-1194"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm1101-1194", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050308225", 
          "https://doi.org/10.1038/nm1101-1194"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.1127592", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062453796"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1160/th04-09-0578", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063290288"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.01.186", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064204187"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075221300", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-03", 
    "datePublishedReg": "2011-03-01", 
    "description": "BACKGROUND: Predicting the efficacy of antiangiogenic therapy would be of clinical value in patients (pts) with metastatic renal cell carcinoma (mRCC). We tested the hypothesis that circulating endothelial cell (CEC), bone marrow-derived CD45(dim)CD34(+)VEGFR2(+) progenitor cell or plasma angiogenic factor levels are associated with clinical outcome in mRCC pts undergoing treatment with tyrosine kinase inhibitors (TKI).\nMETHODS: Fifty-five mRCC pts were prospectively monitored at baseline (day 1) and day 14 during treatment (46 pts received sunitinib and 9 pts received sorafenib). Circulating endothelial cells (CD45(-)CD31(+)CD146(+)7-amino-actinomycin (7AAD)(-) cells) were measured in 1\u2009ml whole blood using four-color flow cytometry (FCM). Circulating CD45(dim)CD34(+)VEGFR2(+)7AAD(-) progenitor cells were measured in progenitor-enriched fractions by four-color FCM. Plasma VEGF, sVEGFR2, SDF-1\u03b1 and sVCAM-1 levels were determined by ELISA. Correlations between baseline CEC, CD45(dim)CD34(+)VEGFR2(+)7AAD(-) progenitor cells, plasma factors, as well as day 1-day 14 changes in CEC, CD45(dim)CD34(+)VEGFR2(+)7AAD(-) progenitor, plasma factor levels, and response to TKI, progression-free survival (PFS) and overall survival (OS) were examined.\nRESULTS: No significant correlation between markers and response to TKI was observed. No association between baseline CEC, plasma VEGF, sVEGFR-2, SDF-1\u03b1, sVCAM-1 levels with PFS and OS was observed. However, baseline CD45(dim)CD34(+)VEGFR2(+)7AAD(-) progenitor cell levels were associated with PFS (P=0.01) and OS (P=0.006). Changes in this population and in SDF-1\u03b1 levels between day 1 and day 14 were associated with PFS (P=0.03, P=0.002). Changes in VEGF and SDF-1\u03b1 levels were associated with OS (P=0.02, P=0.007).\nCONCLUSION: Monitoring CD45(dim)CD34(+)VEGFR2(+) progenitor cells, plasma VEGF and SDF-1\u03b1 levels could be of clinical interest in TKI-treated mRCC pts to predict outcome.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/bjc.2011.72", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "104"
      }
    ], 
    "name": "Levels of circulating CD45dimCD34+VEGFR2+ progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors", 
    "pagination": "1144", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "84656fe8ffc182c7d727ba4587ff677233bd17a17f76c89b9f6449d3a66a011e"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21386843"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0370635"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bjc.2011.72"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1027792566"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bjc.2011.72", 
      "https://app.dimensions.ai/details/publication/pub.1027792566"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T01:48", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8700_00000435.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/bjc201172"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bjc.2011.72'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bjc.2011.72'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bjc.2011.72'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bjc.2011.72'


 

This table displays all metadata directly associated to this object as RDF triples.

301 TRIPLES      21 PREDICATES      76 URIs      38 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bjc.2011.72 schema:about N094d6ed43cf7496c9037e4bd7e3841b0
2 N16d9974d9ef0468e9fc5fbbb0fdeea6a
3 N33c3f5f12cff4d6dbd57e044f4412445
4 N3617b569d3994ef6bf0e979ed9e0e4ea
5 N397ceafe56b247d2bc2cdca4ce1ce675
6 N59a0f24053cf4b35804537a5345c5842
7 N5dc609e5a67b42ada6f9bde2e2695f48
8 N6be15b880539415aabb1ec59df26ef68
9 N89f8fc5ee06146cc83c10d3dd54bb3e8
10 N960d8f8229df45faaca12a3817834e16
11 Nac5c3e3ff15540d3ab80570a3c9f88a4
12 Nb22460c4a30044dba150258c8c4c2c48
13 Nb3a11306e8134bbcbecbc6bcabbc2935
14 Ne32700518a714d8094ead2d0ede63816
15 Ne7ddd31bff0841649cda373991f945ad
16 Ne87b3b6aded34115b0e990344447f4a3
17 Nf5ecd829c01d426eb23a43fa327090a5
18 anzsrc-for:11
19 anzsrc-for:1103
20 schema:author Nd4de32834e3b4279a4bed1b02a18673a
21 schema:citation sg:pub.10.1038/nature04186
22 sg:pub.10.1038/nm1101-1194
23 sg:pub.10.1038/nm1200
24 sg:pub.10.1038/nm988
25 sg:pub.10.1038/nrc1946
26 sg:pub.10.1038/nrc2442
27 sg:pub.10.1038/sj.bjc.6604383
28 sg:pub.10.1038/sj.bjc.6605477
29 sg:pub.10.1186/1479-5876-5-32
30 https://app.dimensions.ai/details/publication/pub.1075221300
31 https://doi.org/10.1016/j.ccr.2006.11.021
32 https://doi.org/10.1016/j.jim.2008.07.006
33 https://doi.org/10.1016/s0022-5347(05)68049-4
34 https://doi.org/10.1056/nejmoa060655
35 https://doi.org/10.1056/nejmoa065044
36 https://doi.org/10.1073/pnas.0507158102
37 https://doi.org/10.1073/pnas.0708148104
38 https://doi.org/10.1073/pnas.0710516105
39 https://doi.org/10.1093/annonc/mdm367
40 https://doi.org/10.1093/emboj/18.14.3964
41 https://doi.org/10.1097/moh.0b013e32832bbcab
42 https://doi.org/10.1101/gad.436307
43 https://doi.org/10.1126/science.1127592
44 https://doi.org/10.1126/science.1150224
45 https://doi.org/10.1158/0008-5472.can-04-1443
46 https://doi.org/10.1158/1078-0432.ccr-08-2363
47 https://doi.org/10.1160/th04-09-0578
48 https://doi.org/10.1200/jco.2005.01.186
49 https://doi.org/10.1200/jco.2008.19.5511
50 https://doi.org/10.1593/neo.05592
51 schema:datePublished 2011-03
52 schema:datePublishedReg 2011-03-01
53 schema:description BACKGROUND: Predicting the efficacy of antiangiogenic therapy would be of clinical value in patients (pts) with metastatic renal cell carcinoma (mRCC). We tested the hypothesis that circulating endothelial cell (CEC), bone marrow-derived CD45(dim)CD34(+)VEGFR2(+) progenitor cell or plasma angiogenic factor levels are associated with clinical outcome in mRCC pts undergoing treatment with tyrosine kinase inhibitors (TKI). METHODS: Fifty-five mRCC pts were prospectively monitored at baseline (day 1) and day 14 during treatment (46 pts received sunitinib and 9 pts received sorafenib). Circulating endothelial cells (CD45(-)CD31(+)CD146(+)7-amino-actinomycin (7AAD)(-) cells) were measured in 1 ml whole blood using four-color flow cytometry (FCM). Circulating CD45(dim)CD34(+)VEGFR2(+)7AAD(-) progenitor cells were measured in progenitor-enriched fractions by four-color FCM. Plasma VEGF, sVEGFR2, SDF-1α and sVCAM-1 levels were determined by ELISA. Correlations between baseline CEC, CD45(dim)CD34(+)VEGFR2(+)7AAD(-) progenitor cells, plasma factors, as well as day 1-day 14 changes in CEC, CD45(dim)CD34(+)VEGFR2(+)7AAD(-) progenitor, plasma factor levels, and response to TKI, progression-free survival (PFS) and overall survival (OS) were examined. RESULTS: No significant correlation between markers and response to TKI was observed. No association between baseline CEC, plasma VEGF, sVEGFR-2, SDF-1α, sVCAM-1 levels with PFS and OS was observed. However, baseline CD45(dim)CD34(+)VEGFR2(+)7AAD(-) progenitor cell levels were associated with PFS (P=0.01) and OS (P=0.006). Changes in this population and in SDF-1α levels between day 1 and day 14 were associated with PFS (P=0.03, P=0.002). Changes in VEGF and SDF-1α levels were associated with OS (P=0.02, P=0.007). CONCLUSION: Monitoring CD45(dim)CD34(+)VEGFR2(+) progenitor cells, plasma VEGF and SDF-1α levels could be of clinical interest in TKI-treated mRCC pts to predict outcome.
54 schema:genre research_article
55 schema:inLanguage en
56 schema:isAccessibleForFree true
57 schema:isPartOf N01ae6b3d39e6495d8adb0c2e0c31a8c1
58 Nf871526299c64d1ab5e5a32846f46785
59 sg:journal.1017082
60 schema:name Levels of circulating CD45dimCD34+VEGFR2+ progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors
61 schema:pagination 1144
62 schema:productId N1f06e61608324bdda3c355cb85ad7a85
63 N4eefec367fe74282bb3f7a2b9f38dcc0
64 N71efd5ca520c4699bf0d92c588d49106
65 N8750d9495f8c45c39cc3d2ff5c99cd86
66 N9d83f65445e64bbc87d8549e5a61140c
67 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027792566
68 https://doi.org/10.1038/bjc.2011.72
69 schema:sdDatePublished 2019-04-11T01:48
70 schema:sdLicense https://scigraph.springernature.com/explorer/license/
71 schema:sdPublisher N3464a18179234a29a8b681409a9e47d9
72 schema:url https://www.nature.com/articles/bjc201172
73 sgo:license sg:explorer/license/
74 sgo:sdDataset articles
75 rdf:type schema:ScholarlyArticle
76 N01ae6b3d39e6495d8adb0c2e0c31a8c1 schema:issueNumber 7
77 rdf:type schema:PublicationIssue
78 N094d6ed43cf7496c9037e4bd7e3841b0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Hematopoietic Stem Cells
80 rdf:type schema:DefinedTerm
81 N16d9974d9ef0468e9fc5fbbb0fdeea6a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Vascular Endothelial Growth Factor Receptor-2
83 rdf:type schema:DefinedTerm
84 N1e7b138b429b402f96ccfc4073701c36 rdf:first sg:person.0660375370.75
85 rdf:rest N7ba34e458639433a87ab54bc6830c68c
86 N1f06e61608324bdda3c355cb85ad7a85 schema:name pubmed_id
87 schema:value 21386843
88 rdf:type schema:PropertyValue
89 N2e2a6f34c225435aad7138f5e677730c rdf:first sg:person.01360655007.23
90 rdf:rest Nd444fb9a32fe43ca96e4dff3f7703971
91 N33c3f5f12cff4d6dbd57e044f4412445 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Antigens, CD34
93 rdf:type schema:DefinedTerm
94 N3464a18179234a29a8b681409a9e47d9 schema:name Springer Nature - SN SciGraph project
95 rdf:type schema:Organization
96 N3617b569d3994ef6bf0e979ed9e0e4ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Male
98 rdf:type schema:DefinedTerm
99 N397ceafe56b247d2bc2cdca4ce1ce675 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Treatment Outcome
101 rdf:type schema:DefinedTerm
102 N47fb7089c3a246449e81562401efb7a0 rdf:first sg:person.01304252172.82
103 rdf:rest rdf:nil
104 N4ed6cab67a96468e9c476536f10671af rdf:first sg:person.01252672277.93
105 rdf:rest Nfe2bb6136f854e5ea214136aadcbac6e
106 N4eefec367fe74282bb3f7a2b9f38dcc0 schema:name dimensions_id
107 schema:value pub.1027792566
108 rdf:type schema:PropertyValue
109 N5529e90b52ae4307beb6dc5e8b895477 rdf:first sg:person.0601364507.58
110 rdf:rest N47fb7089c3a246449e81562401efb7a0
111 N59a0f24053cf4b35804537a5345c5842 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Aged, 80 and over
113 rdf:type schema:DefinedTerm
114 N5dc609e5a67b42ada6f9bde2e2695f48 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Middle Aged
116 rdf:type schema:DefinedTerm
117 N6be15b880539415aabb1ec59df26ef68 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Kidney Neoplasms
119 rdf:type schema:DefinedTerm
120 N71efd5ca520c4699bf0d92c588d49106 schema:name nlm_unique_id
121 schema:value 0370635
122 rdf:type schema:PropertyValue
123 N7ba34e458639433a87ab54bc6830c68c rdf:first sg:person.01036122025.82
124 rdf:rest Nbcf812ba9c90437f9844ccbb9d1b835f
125 N8750d9495f8c45c39cc3d2ff5c99cd86 schema:name readcube_id
126 schema:value 84656fe8ffc182c7d727ba4587ff677233bd17a17f76c89b9f6449d3a66a011e
127 rdf:type schema:PropertyValue
128 N89f8fc5ee06146cc83c10d3dd54bb3e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Protein-Tyrosine Kinases
130 rdf:type schema:DefinedTerm
131 N960d8f8229df45faaca12a3817834e16 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Protein Kinase Inhibitors
133 rdf:type schema:DefinedTerm
134 N9d83f65445e64bbc87d8549e5a61140c schema:name doi
135 schema:value 10.1038/bjc.2011.72
136 rdf:type schema:PropertyValue
137 Nac5c3e3ff15540d3ab80570a3c9f88a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Carcinoma, Renal Cell
139 rdf:type schema:DefinedTerm
140 Nb22460c4a30044dba150258c8c4c2c48 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Vascular Endothelial Growth Factor A
142 rdf:type schema:DefinedTerm
143 Nb3a11306e8134bbcbecbc6bcabbc2935 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Leukocyte Common Antigens
145 rdf:type schema:DefinedTerm
146 Nbcf812ba9c90437f9844ccbb9d1b835f rdf:first sg:person.0770006625.60
147 rdf:rest N2e2a6f34c225435aad7138f5e677730c
148 Nd444fb9a32fe43ca96e4dff3f7703971 rdf:first sg:person.01362554046.97
149 rdf:rest N5529e90b52ae4307beb6dc5e8b895477
150 Nd4de32834e3b4279a4bed1b02a18673a rdf:first sg:person.01126051072.51
151 rdf:rest N4ed6cab67a96468e9c476536f10671af
152 Ne32700518a714d8094ead2d0ede63816 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Adult
154 rdf:type schema:DefinedTerm
155 Ne7ddd31bff0841649cda373991f945ad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Female
157 rdf:type schema:DefinedTerm
158 Ne87b3b6aded34115b0e990344447f4a3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Aged
160 rdf:type schema:DefinedTerm
161 Nf5ecd829c01d426eb23a43fa327090a5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Humans
163 rdf:type schema:DefinedTerm
164 Nf871526299c64d1ab5e5a32846f46785 schema:volumeNumber 104
165 rdf:type schema:PublicationVolume
166 Nfe2bb6136f854e5ea214136aadcbac6e rdf:first sg:person.01360076563.47
167 rdf:rest N1e7b138b429b402f96ccfc4073701c36
168 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
169 schema:name Medical and Health Sciences
170 rdf:type schema:DefinedTerm
171 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
172 schema:name Clinical Sciences
173 rdf:type schema:DefinedTerm
174 sg:journal.1017082 schema:issn 0007-0920
175 1532-1827
176 schema:name British Journal of Cancer
177 rdf:type schema:Periodical
178 sg:person.01036122025.82 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
179 schema:familyName Vimond
180 schema:givenName N
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036122025.82
182 rdf:type schema:Person
183 sg:person.01126051072.51 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
184 schema:familyName Farace
185 schema:givenName F
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126051072.51
187 rdf:type schema:Person
188 sg:person.01252672277.93 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
189 schema:familyName Gross-Goupil
190 schema:givenName M
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252672277.93
192 rdf:type schema:Person
193 sg:person.01304252172.82 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
194 schema:familyName Escudier
195 schema:givenName B
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01304252172.82
197 rdf:type schema:Person
198 sg:person.01360076563.47 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
199 schema:familyName Tournay
200 schema:givenName E
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01360076563.47
202 rdf:type schema:Person
203 sg:person.01360655007.23 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
204 schema:familyName Billiot
205 schema:givenName F
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01360655007.23
207 rdf:type schema:Person
208 sg:person.01362554046.97 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
209 schema:familyName Mauguen
210 schema:givenName A
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362554046.97
212 rdf:type schema:Person
213 sg:person.0601364507.58 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
214 schema:familyName Hill
215 schema:givenName C
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601364507.58
217 rdf:type schema:Person
218 sg:person.0660375370.75 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
219 schema:familyName Taylor
220 schema:givenName M
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660375370.75
222 rdf:type schema:Person
223 sg:person.0770006625.60 schema:affiliation https://www.grid.ac/institutes/grid.14925.3b
224 schema:familyName Jacques
225 schema:givenName N
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0770006625.60
227 rdf:type schema:Person
228 sg:pub.10.1038/nature04186 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001795574
229 https://doi.org/10.1038/nature04186
230 rdf:type schema:CreativeWork
231 sg:pub.10.1038/nm1101-1194 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050308225
232 https://doi.org/10.1038/nm1101-1194
233 rdf:type schema:CreativeWork
234 sg:pub.10.1038/nm1200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020541056
235 https://doi.org/10.1038/nm1200
236 rdf:type schema:CreativeWork
237 sg:pub.10.1038/nm988 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003700365
238 https://doi.org/10.1038/nm988
239 rdf:type schema:CreativeWork
240 sg:pub.10.1038/nrc1946 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018735013
241 https://doi.org/10.1038/nrc1946
242 rdf:type schema:CreativeWork
243 sg:pub.10.1038/nrc2442 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013847179
244 https://doi.org/10.1038/nrc2442
245 rdf:type schema:CreativeWork
246 sg:pub.10.1038/sj.bjc.6604383 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035947940
247 https://doi.org/10.1038/sj.bjc.6604383
248 rdf:type schema:CreativeWork
249 sg:pub.10.1038/sj.bjc.6605477 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020767820
250 https://doi.org/10.1038/sj.bjc.6605477
251 rdf:type schema:CreativeWork
252 sg:pub.10.1186/1479-5876-5-32 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001875982
253 https://doi.org/10.1186/1479-5876-5-32
254 rdf:type schema:CreativeWork
255 https://app.dimensions.ai/details/publication/pub.1075221300 schema:CreativeWork
256 https://doi.org/10.1016/j.ccr.2006.11.021 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000989893
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1016/j.jim.2008.07.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037057792
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1016/s0022-5347(05)68049-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027421869
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1056/nejmoa060655 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025111240
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1056/nejmoa065044 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007947936
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1073/pnas.0507158102 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002444282
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1073/pnas.0708148104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000397108
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1073/pnas.0710516105 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004176363
271 rdf:type schema:CreativeWork
272 https://doi.org/10.1093/annonc/mdm367 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040378769
273 rdf:type schema:CreativeWork
274 https://doi.org/10.1093/emboj/18.14.3964 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000096470
275 rdf:type schema:CreativeWork
276 https://doi.org/10.1097/moh.0b013e32832bbcab schema:sameAs https://app.dimensions.ai/details/publication/pub.1010572209
277 rdf:type schema:CreativeWork
278 https://doi.org/10.1101/gad.436307 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023814636
279 rdf:type schema:CreativeWork
280 https://doi.org/10.1126/science.1127592 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062453796
281 rdf:type schema:CreativeWork
282 https://doi.org/10.1126/science.1150224 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044864905
283 rdf:type schema:CreativeWork
284 https://doi.org/10.1158/0008-5472.can-04-1443 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014291431
285 rdf:type schema:CreativeWork
286 https://doi.org/10.1158/1078-0432.ccr-08-2363 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038609521
287 rdf:type schema:CreativeWork
288 https://doi.org/10.1160/th04-09-0578 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063290288
289 rdf:type schema:CreativeWork
290 https://doi.org/10.1200/jco.2005.01.186 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064204187
291 rdf:type schema:CreativeWork
292 https://doi.org/10.1200/jco.2008.19.5511 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017988502
293 rdf:type schema:CreativeWork
294 https://doi.org/10.1593/neo.05592 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034339541
295 rdf:type schema:CreativeWork
296 https://www.grid.ac/institutes/grid.14925.3b schema:alternateName Institut Gustave Roussy
297 schema:name Department of Biostatistics, Institut de Cancérologie Gustave Roussy, Villejuif, France
298 Department of Medicine, Institut de Cancérologie Gustave Roussy, Villejuif, France
299 INSERM U 981 ‘Identification of molecular predictors and new targets for cancer treatment’, Institut de Cancérologie Gustave Roussy, University of Paris-Sud, Villejuif, France
300 Translational Research Laboratory, Institut de Cancérologie Gustave Roussy, 114 rue Edouard Vaillant, 94805 Villejuif, France
301 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...